[go: up one dir, main page]

YU49486B - Processes and intermediates for preparing 1-benzyl-4-((5,6-dimethoxy-1-indanon)-2-yl) methylpiperidine - Google Patents

Processes and intermediates for preparing 1-benzyl-4-((5,6-dimethoxy-1-indanon)-2-yl) methylpiperidine

Info

Publication number
YU49486B
YU49486B YU66096A YU66096A YU49486B YU 49486 B YU49486 B YU 49486B YU 66096 A YU66096 A YU 66096A YU 66096 A YU66096 A YU 66096A YU 49486 B YU49486 B YU 49486B
Authority
YU
Yugoslavia
Prior art keywords
indanon
methylpiperidine
dimethoxy
intermediates
benzyl
Prior art date
Application number
YU66096A
Other languages
Serbo-Croatian (sh)
Other versions
YU66096A (en
Inventor
Keith M. Devries
Original Assignee
Pfizer Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc. filed Critical Pfizer Inc.
Publication of YU66096A publication Critical patent/YU66096A/en
Publication of YU49486B publication Critical patent/YU49486B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/30Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
    • C07D211/32Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Jedinjenja formule naznačeno time, što R1 je R2 O(C=O)-, R2 je (C1-C4)alkil. Prijava sadrži još 4 nezavisna i 11 zavisnih patentnih zahteva.Compounds of formula wherein R 1 is R 2 O (C = O) -, R 2 is (C 1 -C 4) alkyl. The application contains 4 more independent and 11 dependent patent claims.

YU66096A 1995-12-15 1996-12-11 Processes and intermediates for preparing 1-benzyl-4-((5,6-dimethoxy-1-indanon)-2-yl) methylpiperidine YU49486B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US875395P 1995-12-15 1995-12-15

Publications (2)

Publication Number Publication Date
YU66096A YU66096A (en) 1999-11-22
YU49486B true YU49486B (en) 2006-08-17

Family

ID=21733469

Family Applications (1)

Application Number Title Priority Date Filing Date
YU66096A YU49486B (en) 1995-12-15 1996-12-11 Processes and intermediates for preparing 1-benzyl-4-((5,6-dimethoxy-1-indanon)-2-yl) methylpiperidine

Country Status (33)

Country Link
EP (1) EP0883607A1 (en)
JP (1) JP3066083B2 (en)
KR (1) KR20000064387A (en)
AP (1) AP708A (en)
AR (1) AR004368A1 (en)
AU (1) AU716462B2 (en)
BG (1) BG102525A (en)
BR (1) BR9612018A (en)
CA (1) CA2237647A1 (en)
CO (1) CO4750831A1 (en)
CZ (1) CZ180898A3 (en)
DZ (1) DZ2141A1 (en)
GT (1) GT199600092A (en)
HN (1) HN1996000065A (en)
HR (1) HRP960592A2 (en)
HU (1) HUP9904275A3 (en)
IL (3) IL136420A0 (en)
IS (1) IS4752A (en)
MA (1) MA24032A1 (en)
NO (1) NO982712L (en)
NZ (1) NZ318843A (en)
OA (1) OA10694A (en)
PE (1) PE25698A1 (en)
PL (1) PL197306B1 (en)
RO (1) RO121382B1 (en)
RU (1) RU2160731C2 (en)
SK (1) SK75498A3 (en)
TN (1) TNSN96153A1 (en)
TW (1) TW414787B (en)
UY (1) UY24401A1 (en)
WO (1) WO1997022584A1 (en)
YU (1) YU49486B (en)
ZA (1) ZA9610533B (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE292116T1 (en) 1998-01-16 2005-04-15 Eisai Co Ltd METHOD FOR PRODUCING DONEPEZIL DERIVATIVES
IL125809A (en) * 1998-08-17 2005-08-31 Finetech Lab Ltd Process and intermediates for production of donepezil and related compounds
US7148354B2 (en) * 2002-07-24 2006-12-12 Dr. Reddy's Laboratories Limited Process for preparation of donepezil
IL150982A (en) 2002-07-30 2007-02-11 Ori Lerman Process for the preparation of donepezil
IL151253A0 (en) * 2002-08-14 2003-04-10 Finetech Lab Ltd Process for production of highly pure donepezil hydrochloride
US6649765B1 (en) 2003-02-12 2003-11-18 Usv Limited, Bsd Marg. Process for the preparation of 1-benzyl-4(5,6-dimethoxy-1-indanon)-2-yl) methyl piperidine hydrochloride (Donepezil HCL)
US6953856B2 (en) 2003-02-12 2005-10-11 Usv, Limited Process for the preparation of 1-benzyl-4-(5,6-dimethoxy-1-indanon)-2-yl) methyl piperidine hydrochloride (Donepezil HCI)
US20070129549A1 (en) * 2003-03-21 2007-06-07 Yatendra Kumar Stable lamotrigine pharmaceutical compositions and processes for their preparation
WO2004099142A1 (en) * 2003-05-05 2004-11-18 Ranbaxy Laboratories Limited Hydrobromide salt of benzyl-piperidylmethyl-indanone and its polymorphs
EP1654230A1 (en) 2003-07-01 2006-05-10 Hetero Drugs Limited Preparation of intermediates for acetyl cholinesterase inhibitors
CN1280273C (en) 2003-11-05 2006-10-18 天津和美生物技术有限公司 Synthesis of donepizin and its derivative
WO2006035433A2 (en) 2004-09-29 2006-04-06 Chemagis Ltd. Use of purified donepezil maleate for preparing pharmaceutically pure amorphous donepezil hydrochloride
CN100436416C (en) * 2005-07-29 2008-11-26 西南合成制药股份有限公司 Novel donepezil synthesis process
GB0515803D0 (en) 2005-07-30 2005-09-07 Pliva Hrvatska D O O Intermediate compounds
AR057910A1 (en) 2005-11-18 2007-12-26 Synthon Bv PROCESS TO PREPARE DONEPEZILO
KR20080085195A (en) * 2006-01-04 2008-09-23 씨아이피엘에이 엘티디. Preparation method and intermediate of donepezil
EP2114166A4 (en) 2006-12-11 2011-05-25 Reviva Pharmaceuticals Inc Compositions, synthesis, and methods of using indanone based cholinesterase inhibitors
WO2013078608A1 (en) 2011-11-29 2013-06-06 Ziqiang Gu Donepezil pamoate and methods of making and using the same
US10357486B2 (en) 2013-08-16 2019-07-23 Universiteit Maastricht Treatment of cognitive impairment with PDE4 inhibitor

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI95572C (en) * 1987-06-22 1996-02-26 Eisai Co Ltd Process for the preparation of a medicament useful as a piperidine derivative or its pharmaceutical salt
FR2642069B1 (en) * 1989-01-20 1991-04-12 Rhone Poulenc Sante NOVEL BENZOPYRAN DERIVATIVES, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
DE4439822A1 (en) * 1994-11-08 1996-08-29 Bayer Ag Process for the preparation of benzyl-piperidylmethyl-indanones

Also Published As

Publication number Publication date
RO121382B1 (en) 2007-04-30
RU2160731C2 (en) 2000-12-20
YU66096A (en) 1999-11-22
CO4750831A1 (en) 1999-03-31
DZ2141A1 (en) 2002-07-23
HUP9904275A3 (en) 2001-05-28
KR20000064387A (en) 2000-11-06
BG102525A (en) 1999-05-31
IL136421A0 (en) 2001-06-14
NZ318843A (en) 2000-01-28
CZ180898A3 (en) 1999-05-12
UY24401A1 (en) 1997-06-09
HRP960592A2 (en) 1998-06-30
AU716462B2 (en) 2000-02-24
BR9612018A (en) 1999-02-17
WO1997022584A1 (en) 1997-06-26
HUP9904275A2 (en) 2000-05-28
AP9600892A0 (en) 1997-01-31
ZA9610533B (en) 1998-06-15
JP3066083B2 (en) 2000-07-17
OA10694A (en) 2001-05-04
MX9804820A (en) 1998-10-31
PE25698A1 (en) 1998-05-21
IL136420A0 (en) 2001-06-14
JPH11500756A (en) 1999-01-19
NO982712D0 (en) 1998-06-12
GT199600092A (en) 1998-05-12
CA2237647A1 (en) 1997-06-26
AR004368A1 (en) 1998-11-04
PL327512A1 (en) 1998-12-21
IS4752A (en) 1998-05-22
AU7092596A (en) 1997-07-14
PL197306B1 (en) 2008-03-31
NO982712L (en) 1998-06-12
AP708A (en) 1998-12-04
MA24032A1 (en) 1997-07-01
HN1996000065A (en) 1997-06-26
EP0883607A1 (en) 1998-12-16
IL124452A0 (en) 1998-12-06
SK75498A3 (en) 1999-08-06
TW414787B (en) 2000-12-11
TNSN96153A1 (en) 2005-03-15

Similar Documents

Publication Publication Date Title
YU49486B (en) Processes and intermediates for preparing 1-benzyl-4-((5,6-dimethoxy-1-indanon)-2-yl) methylpiperidine
ATE211732T1 (en) N-BENZYLPIPERIDINE AND TETRAHYDROPYRIDINE DERIVATIVES
NO996269L (en) Quinoline-indole antimicrobial agents, as well as the use and mixtures thereof
ATE269312T1 (en) N-(AMIDINOPHENYL)-N'-(NOUN)-3H-2,4-BENZODIAZEPINE-3-ONE DERIVATIVES AS FACTOR XA INHIBITORS
NO20051600L (en) 1,4-disubstituted piperidine derivatives and their use as 11-betaHSD1 inhibitors
NO20004121L (en) New compounds and their use as positive AMPA receptor modulators
EA199800141A1 (en) HETEROCYCLIC COMPOUNDS
DK51986A (en) HETEROCYCLIC COMPOUNDS, THEIR PREPARATION AND USE AS INSECTICIDE AGENTS
NO973635L (en) Method of inhibiting cell-cell adhesion
YU9802A (en) Cell adhesion inhibitors
NO963370L (en) Novel mercaptoacetylamido-1,3,4,5-tetrahydrobenzo [cazazepin-3-one disulfide derivatives useful as inhibitors of enkephalinase and ACE
NO944406L (en) New 7 e inhibitors
ES2104090T3 (en) NEW 3 ', 5'-DI-T-BUTIL-4'-HIDROXI-FLAVONAS, ITS PREPARATION PROCEDURE AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
NO971625L (en) Novel peptides with immunomodulatory effects
NO984740L (en) Isatin derivatives such as acetylcholinesterase inhibitors and analgesics
NO944926L (en) Methods for Inhibiting Myeloperoxidase Activity
NO932431L (en) PROCEDURE AND INTERMEDIATES FOR THE MANUFACTURE OF AZABICYCLO (2,2,2) OCTAN-3-IMINES
ES2152563T3 (en) PROCEDURE TO PREPARE DERIVATIVES OF DIHYDROXIPIRIMIDINE.
HUP9901093A2 (en) Use of benzotiophene derivatives for production of pharmaceuticals inhibiting melanoma
NO981578L (en) Method of inhibiting plasminogen activator inhibitor I
ATE158301T1 (en) 4-AZA-PREGNAN-5-ALPHA-REDUCTASE ISOZYME 1 INHIBITORS
HK18082A (en) Hexahydroazepine, piperidine and pyrrolidine derivatives
TW346483B (en) Benzene derivatives
NO981909L (en) Fungicidal Compounds (B)
NO944909L (en) Methods for inhibiting male infertility